# A Classroom Study to Assess the Time of Onset of Vyvanse (Lisdexamfetamine Dimesylate) in Pediatric Subjects Aged 6-12 With Attention Deficit/Hyperactivity Disorder (ADHD)

> **NCT00500149** · PHASE3 · COMPLETED · sponsor: **Shire** · enrollment: 129 (actual)

## Conditions studied

- ADHD

## Interventions

- **DRUG:** Vyvanse (lisdexamfetamine dimesylate)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00500149
- **Lead sponsor:** Shire
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-06-13
- **Primary completion:** 2007-12-05
- **Final completion:** 2007-12-05
- **Target enrollment:** 129 (ACTUAL)
- **Last updated:** 2021-06-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00500149

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00500149, "A Classroom Study to Assess the Time of Onset of Vyvanse (Lisdexamfetamine Dimesylate) in Pediatric Subjects Aged 6-12 With Attention Deficit/Hyperactivity Disorder (ADHD)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00500149. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*